Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Start-Ups in Biotechnology

This article was originally published in Start Up

Executive Summary

For start-ups in biotech, it's the worst and the best of times. On the one hand, new opportunities and new sources of financing. On the other, too many companies and cutthroat competition. Interviews with venture capitalist Lawrence Bock, Peter Drake,PhD, of Vector Securities, and Richard Dimarchi, PhD, vice president of research technology and proteins for Eli Lilly & Co., shed light on current trends.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts